Twinlab Corporation Issues Statement in Response to FDA Warning Letter Concerning Androstenedione.

HAUPPAUGE, N.Y., March 12 /PRNewswire/ -- Twinlab Corporation, a wholly-owned subsidiary of IdeaSphere, Inc. today issued the following statement in response to the US Food and Drug Administration's warning letter to Twinlab Corporation concerning products containing androstenedione, or "andro":

         Twinlab Corporation respectfully disagrees with the conclusions
         drawn in the FDA warning letter and is in the process of preparing
         an appropriate response that will be submitted within the allowable
         response period.

         We believe that Twinlab androstenedione products are safe and
         effective if used as directed. When IdeaSphere, Inc. acquired the
         Twinlab assets in December 2003, the decision was made in view of
         the declining market for androstenediol/androstenedione products
         and the availability of new ingredients not to offer these products
         on a go-forward basis. In support of that decision, IdeaSphere Inc.
         did not acquire any assets related to androstenediol products.  It
         did acquire pre-existing inventory of Twinlab's Andro Fuel product,
         which contains androstenedione, however this is residual inventory
         that is being phased out of the market.

         Twinlab is currently manufacturing and will commence selling a new
         performance product, Andro Nitrate 4 Fuel, in April 2004.  This
         product contains no androstenediol and no androstenedione.  "Andro"
         is a longstanding Twinlab brand name drawing its identity from the
         Greek root meaning "male" or "masculine," and will be retained for
         that reason.

         IdeaSphere Inc. and Twinlab Corporation share the FDA's commitment
         to science and safety - we are science-focused and research-driven.
         Notwithstanding this disagreement, Twinlab remains committed to the
         principle that by working hand in hand with the FDA on this and
         other matters, Twinlab, the industry, and ultimately the consumer
         all win.

  About Twinlab

Twinlab, based in Hauppauge, NY, is the leading manufacturer and marketer of high quality, science-based, nutritional supplements, including a robust line of vitamins, minerals, specialty supplements, herbs, teas and sports nutrition products.

About IdeaSphere, Inc.

IdeaSphere, Inc., with offices in New York, NY, Hauppauge, NY, Grand Rapids, Michigan, and American Fork, Utah, is the champion of the Wellness Revolution. A purpose-built, vertically integrated health and wellness company, it provides total wellness solutions through its holdings, which include leaders in wellness products, content and services. IdeaSphere's family of companies includes Twinlab Corporation; Rebus LLC, and iVillage Solutions.

   Contact:  Ross A. Anderson, IdeaSphere, Inc.
             631-467-3140 ext. 8324
             [e-mail]

             Alan Ampolsk, PR21
             212-299-8953
             [e-mail]

CONTACT: Ross A. Anderson, of IdeaSphere, Inc., [phone] ext. 8324, [e-mail]; or Alan Ampolsk of PR21, [phone], [e-mail], for Twinlab Corporation